Follow
Deniz Lengerli
Deniz Lengerli
Verified email at gazi.edu.tr
Title
Cited by
Cited by
Year
A highly potent TACC3 inhibitor as a novel anticancer drug candidate
O Akbulut, D Lengerli, O Saatci, E Duman, UOS Seker, A Isik, A Akyol, ...
Molecular cancer therapeutics 19 (6), 1243-1254, 2020
212020
The 1, 2, 3-triazole ‘all-in-one’ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
D Lengerli, K Ibis, Y Nural, E Banoglu
Expert Opinion on Drug Discovery 17 (11), 1209-1236, 2022
172022
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, M Uner, D Lengerli, ...
Cell Death & Differentiation, 1-15, 2023
62023
Crystal structure and Hirshfeld surface analysis of 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl) methoxy] phenyl}-1, 2-oxazole
A Aydin, M Akkurt, S Turanli, D Lengerli, E Banoglu, ND Ozcelik
Acta Crystallographica Section E: Crystallographic Communications 77 (4 …, 2021
32021
Isoxazole derivatives targeting tacc3 as anticancer agents
E Banoglu, B Caliskan, O Sahin, D Lengerli, O Akbulut, LIM Chaemin, ...
US Patent App. 17/776,767, 2023
2023
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity
S Turanlı, E Nalbat, D Lengerli, K İbiş, S Güntekin Ergün, ...
ACS omega 7 (41), 36206-36226, 2022
2022
Highly potent tacc3 inhibitor as a novel anticancer drug candidate
E Banoglu, B Caliskan, O Sahin, D Lengerli, O Akbulut
US Patent App. 17/058,982, 2021
2021
A novel TACC3 inhibitor as an anti-cancer agent in breast cancer
O Akbulut, D Lengerli, O Saatci, E Duman, U Seker, B Caliskan, ...
Cancer Research 79 (13 Supplement), 3871-3871, 2019
2019
A Novel TACC3 inhibitor as an anti-cancer agent in breast cancer
O Akbulut, D Lengerli, B Caliskan, E Banoglu, O Sahin
EUROPEAN JOURNAL OF CANCER 103, E71-E71, 2018
2018
STUDIES ON THE SYNTHESIS AND ANTICANCER POTENTIAL OF NOVEL 2, 4-DIAMINOPYRIMIDINE DERIVATIVES
D LENGERLİ, Ö AKBULUT ÇALIŞKAN, B ÇALIŞKAN, Ö ŞAHİN, ...
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL IMIDAZOLIDINONE-THIAZOLE AMIDE HYBRIDS AS INHIBITORS OF HUMAN SOLUBLE EPOXIDE HYDROLASE
K İbiş, D Lengerli, P Jordan, B Çalışkan, O Werz, E Banoğlu
Synthesis of New Vicinal Diaryl Five-Membered Heterocyclic Compounds with Potential Anticancer Activity
S TURANLİ, D LENGERLİ, B ÇALIŞKAN, ECE AKHAN GÜZELCAN, ...
Synthesis of 3, 4-Diaryl-5-methylisoxazoles with Potent Antiproliferative Activity Against a Panel of Human Liver and Breast Cancer Cell Lines
D LENGERLİ, S TURANLİ, B ÇALIŞKAN, ECE AKHAN GÜZELCAN, ...
A SMALL MOLECULE INHIBITOR OF TRANSFORMING ACIDICCOILED-COIL PROTEIN 3 (TACC3): A NOVEL THERAPEUTICSTRATEGY FOR THE TREATMENT OF BREAST CANCER
D LENGERLİ, O Akbulut, B ÇALIŞKAN, Ö ŞAHİN, E BANOĞLU
The system can't perform the operation now. Try again later.
Articles 1–14